CA00430K8656 - ACST - A3EP78 (XNCM)
ACASTI PHARMA INC. Aktie
Kein Kurs
Performance
Heute | Woche | Monat | 3 Monate | 6 Monate | 1 Jahr | 5 Jahre |
---|---|---|---|---|---|---|
- | - | -3,73 % | 28,67 % | 1,05 % | 50,06 % | -97,49 % |
Firmenprofil zu ACASTI PHARMA INC. Aktie
Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
Unternehmensdaten zur ACASTI PHARMA INC. Aktie
Name ACASTI PHARMA INC.
Firma Acasti Pharma Inc.
Symbol ACST
Website https://www.acastipharma.com
Heimatbörse
Frankfurt
WKN A3EP78
ISIN CA00430K8656
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Mr. Prashant Kohli
Marktkapitalisierung 31 Mio
Land Kanada
Währung EUR
Mitarbeiter 0,0 T
Adresse 3009 boulevard de la Concorde East, H7E 2B5 Laval
IPO Datum 2012-02-07
Ticker Symbols
Name | Symbol |
---|---|
Frankfurt | A1P0.F |
NASDAQ | ACST |
More Shares
Investors who ACASTI PHARMA INC. hold also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.